Cite
HARVARD Citation
Styczynski, J. et al. (2022). Current attitude to deferral of cellular therapy or nontransplant chemotherapy due to SARS‐CoV‐2 asymptomatic infection: Survey of Infectious Diseases Working Party EBMT. Transplant infectious disease. 24 (2), p. n/a. [Online].